Growth Factors and the Skin Barrier: What Does the Science Say?
Key Facts
- The EGF receptor (EGFR) is expressed in roughly 70% of epidermal keratinocytes; cell division begins within 24-48 hours of binding.
- KGF (Keratinocyte Growth Factor / FGF-7) upregulates stratum corneum lipid synthesis, increasing lamellar body secretion and reducing TEWL by an average of 18-22%.
- A 12-week topical EGF study reported a 34% reduction in fine lines and a 19% increase in epidermal thickness (Fabi & Sundaram, 2014).
- TGF-β1 signaling in fibroblasts weakens with age; this reduces collagen synthesis while limiting barrier repair capacity.
- The effective concentration threshold in growth factor serums is roughly 1-5 ppm (0.0001-0.0005%); a stable formulation and correct pH (4.5-6.5) preservation are essential.
Let's personalize your barrier repair protocol.
Our expert team answers your questions about growth factors and skincare routines on WhatsApp.
Free Consultation LinePharm. Mine Ekber
What Is a Growth Factor? Skin's Endogenous Repair Molecules
Growth factors are polypeptide-based bioactive molecules with molecular weights ranging from 6,000 to 30,000 daltons that govern intercellular communication. In the context of skin, these molecules play a central role in epidermal self-renewal, strengthening the dermal-epidermal junction, and preserving the structural integrity of the skin barrier.Mehta & Fitzpatrick, 2007
The Discovery of EGF and Its Core Properties
Epidermal Growth Factor (EGF) was identified in 1962 by Nobel laureate biochemist Stanley Cohen. This 6,045-dalton molecule, made up of 53 amino acids, triggers keratinocyte mitogenesis by activating the EGFR (EGF Receptor) tyrosine kinase pathway. In skin tissue, EGF is secreted mainly by the salivary glands, fibroblasts, and platelets. When applied topically, its capacity to bind free receptors is directly proportional to formulation viscosity and pH, among other factors.
How Growth Factors Communicate With Cells: The Receptor Cascade
When a growth factor molecule binds to its receptor on the cell surface, two signaling pathways activate simultaneously: the RAS/MAPK pathway regulates cell proliferation, while the PI3K/AKT pathway regulates cell survival and migration. This cascade functions as an "emergency repair program" that kicks in within the first 6-12 hours after barrier damage. Receptor downregulation kicks in as a protective mechanism under excessive stimulation; this is why intermittent-use protocols matter in clinical practice.
EGF and Epidermal Barrier Renewal
EGF's effect on the skin barrier isn't one-dimensional: it both speeds up the epidermis's cellular renewal and supports the stratum corneum integrity that contributes to reducing transepidermal water loss (TEWL).
Keratinocyte Proliferation and Differentiation
When stem cells in the stratum basale receive an EGF signal, their division rate increases and new keratinocyte layers begin forming. But the truly critical effect happens at the differentiation stage: EGF modulates filaggrin and involucrin expression, influencing corneocytes' structural maturation. Since filaggrin is a protein that holds keratin fibers together and supplies NMF (Natural Moisturizing Factor) precursors, EGF's effect in this direction is directly linked to moisture-retention capacity.
EGF and Stratum Corneum Lipid Organization
EGF application increases lamellar body secretion, raising the amount of lipids released into the stratum corneum. Ceramide molecules lead these lipids — preserving the ratios of ceramide 1, 3, and 6-II in particular directly affects barrier permeability. EGF signal activation upregulates serine palmitoyltransferase, the enzyme involved in ceramide synthesis; this mechanism shows that EGF is barrier-protective not just at the cellular level but at the lipid level too.
FGF, KGF, and TGF-β: Other Growth Factors That Complete the Barrier
Beyond EGF, molecules from the fibroblast growth factor family (FGF) and the transforming growth factor beta group (TGF-β) also play complementary roles in skin barrier renewal.
KGF (FGF-7): Keratinocytes' Dedicated Growth Factor
Keratinocyte Growth Factor (KGF) is the 7th member of the FGF family and binds exclusively to the FGFR2b receptor on the keratinocyte surface — this selectivity makes it an epidermal-specific molecule.Werner, 1998 KGF's most notable effect is increasing the number of lamellar bodies and, in turn, the amount of lipid secreted into the stratum corneum. Clinical studies have reported TEWL values dropping by 18-22% after KGF application. In sensitive and reactive skin, formulations that support KGF can reduce redness and dryness symptoms linked to barrier weakness.
TGF-β: A Dual-Direction Effect in Barrier Remodeling
Transforming growth factor beta (TGF-β) is a biphasic molecule that regulates both pro-inflammatory and anti-inflammatory processes. At low concentrations, it stimulates keratinocyte migration, speeding up wound closure; at high concentrations, it inhibits keratinocyte proliferation. On the dermal side, TGF-β1 directs fibroblasts toward collagen synthesis, driving extracellular matrix remodeling. The weakening of TGF-β1 signaling with age leads to progressive loosening at the dermal-epidermal junction.
VEGF and IGF-1: Supporting Roles
Vascular Endothelial Growth Factor (VEGF) increases dermal vascularization, easing the delivery of growth factors and nutrients to the epidermis. Insulin-Like Growth Factor 1 (IGF-1), meanwhile, reinforces fibroblast and keratinocyte proliferation through a mechanism synergistic with EGF. The existence of this multi-growth-factor network shows that holistic barrier-supporting formulations deliver superior clinical results compared to approaches focused on a single molecule.
Growth Factor Serum Application: Absorption, Stability, and Clinical Realities
A growth factor serum's efficacy depends not just on which molecules it contains, but on formulation quality, stabilization method, and the current condition of the barrier it's applied to.
Molecular Weight and Penetration: The Core Constraint
In an intact skin barrier, only molecules under 500 daltons can cross the stratum corneum through passive diffusion — EGF's 6,045-dalton size is 12 times this threshold. This molecular reality directly calls into question the mechanism of topical growth factor use. But research has identified two distinct pathways of effect: (1) In areas where the barrier is compromised (micro-cracks, follicular channels, damage sites), penetration increases significantly. (2) Growth factor molecules bound to surface receptors can transmit their signal inward via finer fractions — this mechanism, known as "outside-in signaling," can produce a biological response even without full penetration.
Clinical Studies: 12 Weeks and Beyond
A 2014 review by Fabi and Sundaram examined randomized controlled trials conducted with topical growth factor products.Fabi & Sundaram, 2014 The main findings observed with 12 weeks of use were: a 28-34% reduction in fine lines, a 19% increase in epidermal thickness, and a 20% rise in collagen density. In the vast majority of studies, EGF concentration was kept in the 1-5 ppm (1-5 μg/mL) range; doses below this threshold showed no meaningful effect. Keeping formulation pH between 4.5 and 6.5 is considered critical for preserving the conformation of protein-based molecules.
The Importance of Stability: Why Isn't Every Serum Equal?
Growth factors are extremely sensitive to heat, light, and oxidation: they rapidly lose bioactivity above 40°C. This is why packaging (opaque, airtight, pump-free droppers are recommended), storage conditions, and expiration date matter as much as the active ingredient itself. Frosted glass or opaque HDPE containers should be preferred; the product should be used within 6 months of opening.
Skin Barrier Damage and the Growth Factor Response
In a healthy barrier, growth factor signaling runs continuously at a low level; but under damage, this system shifts into emergency mode. The integrity of this signaling network is essential for the barrier repair process to function effectively.
The Growth Factor Cascade After UV Damage
When UVB radiation strikes the epidermis, the EGF receptor (EGFR) activates in a ligand-independent manner via reactive oxygen species (ROS) within the first 30 minutes — this "trans-activation" mechanism serves a dual function: an acute repair signal, and a carcinogenesis risk factor under chronic UV damage. In the short term, keratinocyte migration and proliferation are stimulated to close barrier gaps; in the long term, however, excessive EGFR activation has been linked to melanocyte activation.
Declining Growth Factor Levels With Age
Starting in one's 20s, EGF, KGF, and IGF-1 levels begin a progressive decline: by the 50s, endogenous EGF levels run 40-60% lower than in the 20s. This decline runs parallel to keratinocyte turnover time stretching from 20 days to 40-45 days. As a result, barrier repair speed slows, stratum corneum lipid organization breaks down, and TEWL values run chronically elevated. When combined with retinol, growth factor support carries synergistic clinical potential, since it simultaneously targets keratinocyte acceleration and barrier lipid synthesis.
The Relationship Between Barrier Integrity and Growth Factor Efficacy
A paradoxical fact: a damaged barrier is both the condition that needs growth factor support the most and the one where topical application is least effective — because growth factor receptors downregulate in an inflammatory environment. This is why a protocol that repairs the barrier first, then supports it with growth factors, is clinically superior to applying growth factors first and attempting repair afterward.
CIRÈLL's Approach: Growth Factor Synergy Through the Biomimetic TriBarrier System
CIRÈLL builds its approach to growth factor biology not around a single active ingredient, but around an integrated system that simultaneously supports every layer of the barrier. The Biomimetic TriBarrier System rests on units with three simultaneous targets: (1) renewing the lipid matrix, (2) repairing NMF, (3) strengthening tight junctions.
The Barrier Infrastructure That Supports Growth Factor Efficacy
Cell membrane integrity and membrane lipid composition are critical for growth factor receptors to function optimally. In a keratinocyte membrane with a disrupted cholesterol-to-ceramide ratio, EGFR signal transmission weakens significantly. This is why, in CIRÈLL's formulation philosophy, delivering ceramide, cholesterol, and free fatty acids in physiological ratios means preparing a "receptor-compatible" membrane environment in which growth factor signaling can function. Repairing ingredients like madecassoside, meanwhile, naturally activate TGF-β-like pathways, supporting collagen synthesis and forming a complementary foundation for the growth factor network.
Keratinocyte proliferation and NMF precursor synthesis; upregulates the ceramide synthesis enzyme.
Increases lamellar body secretion; reduces TEWL by 18-22%.
Drives fibroblast collagen synthesis; declines in aging skin.
Synergistic keratinocyte proliferation with EGF; supports fibroblast viability.
| Growth Factor | Target Cell | Effect on the Barrier | Decline Age |
|---|---|---|---|
| EGF | Keratinocyte, fibroblast | Stratum corneum renewal, ceramide synthesis | 25+ |
| KGF (FGF-7) | Keratinocyte | Lamellar lipid secretion, TEWL reduction | 30+ |
| TGF-β1 | Fibroblast, keratinocyte | Collagen renewal, extracellular matrix | 35+ |
| IGF-1 | Fibroblast, keratinocyte | Epidermal thickness, barrier turnover speed | 30+ |
| VEGF | Endothelial cell | Dermal vascularization, nutrient delivery | 40+ |
The Right Growth Factor Protocol: A Step-by-Step Guide
Application order and preparation stage are critical for maximizing a growth factor serum's efficacy. Growth factor application without regard to barrier condition doesn't deliver the expected result.
Use a mildly acidic cleanser in the pH 4.5-5.5 range if possible. Alkaline cleansers reduce EGFR activity.
Humectant-based toners that pre-hydrate the barrier improve the growth factor serum's even distribution.
Apply 2-3 drops to damp skin; pat gently, don't rub. Wait 60-90 seconds for receptor binding.
Lock in the active from the growth factor serum with a moisturizer containing ceramide and cholesterol. This step reduces TEWL and extends the penetration window.
UVB activates EGFR in a ligand-independent manner; sunscreen is the mandatory final step of the growth factor protocol.
These Signs May Point to a Growth Factor Deficiency
When the barrier's renewal capacity declines, certain clinical findings pointing to insufficient growth factor signaling show up on the skin surface.
Small injuries (extracting a blackhead, light peeling) taking longer than normal to heal can indicate that keratinocyte turnover speed has dropped and EGF signaling has weakened.
Persistent dryness despite moisturizer application points to insufficient lamellar lipid secretion — this process is directly linked to KGF and EGF's effect on lamellar body activity.
When tight junction proteins (claudin, occludin) — stabilized by KGF signaling — decline, paracellular permeability rises; this increases sensitivity to environmental irritants and sets the stage for reactive skin.
As TGF-β1 signaling declines, dermal collagen synthesis slows; epidermal thickness decreases in parallel. The accelerated formation of fine lines is an early sign that the dermis's renewal capacity is dropping.
Conclusion
Growth factors are the biomolecular foundation of the skin barrier's repair and renewal capacity, and their endogenous levels — which decline with aging, UV damage, and chronic inflammation — can be supported with topical formulations. A solid barrier infrastructure is the precondition for an effective growth factor protocol; in a damaged, inflamed barrier, the sequence of repair first, then growth factor support, determines the clinical outcome. Although growth factor serums' molecular size limits full epidermal penetration, surface receptor activation and the increased permeability in damaged areas make topical application biologically meaningful.
The CIRÈLL Biomimetic TriBarrier System offers an approach that scientifically supports the lipid matrix and cell membrane integrity that growth factor signaling needs; it's formulated on the principle of building not just the active ingredient, but the barrier that active can work within.
Frequently Asked Questions
What is a growth factor and what does it do in skincare?
Growth factors are protein-based bioactive molecules that govern intercellular communication. The main growth factors used in skincare include EGF (Epidermal Growth Factor), KGF (Keratinocyte Growth Factor / FGF-7), TGF-β (Transforming Growth Factor Beta), and IGF-1 (Insulin-Like Growth Factor 1). These molecules bind to receptors on the cell surface to trigger core processes like keratinocyte proliferation, fibroblast activation, collagen synthesis, and epidermal barrier renewal. Since skin's endogenous growth factor production declines with aging and environmental damage, topical supplementation aims to support repair and renewal capacity.
How does EGF repair the skin barrier? What's its mechanism?
When EGF binds to the EGFR (EGF Receptor) tyrosine kinase on the keratinocyte surface, it activates two critical signaling pathways: the RAS/MAPK pathway regulates cell proliferation, while the PI3K/AKT pathway regulates cell migration and survival. Thanks to this cascade, stem cells in the stratum basale divide faster, new keratinocyte layers form, and barrier gaps close. EGF also activates the serine palmitoyltransferase enzyme, increasing ceramide synthesis and supporting lamellar body secretion — repairing the barrier lipid matrix as well. All of these mechanisms kick in within the first 6-12 hours after damage, simultaneously managing both cellular and lipid-based barrier repair.
What's the effective concentration in a growth factor serum?
Clinical studies show that the minimum concentration needed to achieve a biological response in topical EGF serums falls in the 1-5 ppm range (1-5 μg/mL, or 0.0001-0.0005%). Doses below this threshold have been reported to produce no measurable effect. Similar concentration ranges apply for KGF. One key point: effective concentration isn't determined by the label weight, but by the active's stability and the formulation's pH (4.5-6.5). Since high concentrations can lead to receptor downregulation, doses above 5 ppm don't appear to provide additional clinical benefit.
Which products should a growth factor serum be combined with, and which should it avoid?
Growth factor serums can be safely combined with hyaluronic acid, ceramide-containing moisturizers, and niacinamide — this combination offers a synergistic, barrier-supporting effect. Combining with retinol is theoretically powerful (both increase keratinocyte turnover), but initially, separate sessions — growth factor in the morning, retinol at night — are recommended rather than the same session. Mixing directly with products containing high-concentration acid (AHA/BHA, 15%+ vitamin C) can lower pH below 4.5, potentially denaturing the growth factor protein; leave at least 30 minutes between these products or apply them in separate sessions.
Can oily and acne-prone skin use a growth factor serum?
Yes, oily and acne-prone skin can use a growth factor serum — but formulation choice matters. EGF on its own doesn't increase seborrheic activity; however, EGFR signaling is linked to excessive sebum production. This is why, for oily and acne-prone skin, growth factor serums formulated with lightweight, oil-free, non-comedogenic carriers should be preferred. Minimalist serums containing just EGF or KGF alone give more predictable results on oily skin than heavy formulations with numerous active ingredients. Growth factor use on active acne lesions can support lesion healing, but dermatological supervision is recommended during inflammatory acne flares.
At what age should growth factor serum use begin?
There's no fixed starting age for growth factor serums, but clinical guidelines generally note that endogenous EGF and KGF levels begin declining between ages 25-30, and that preventive use is reasonable starting around this age. Before age 30, people with a healthy barrier primarily need sun protection and basic moisturizing; growth factor can be used for "maintenance" rather than "repair" in this age group. From ages 35-40 onward, when keratinocyte turnover slows and collagen synthesis declines, growth factor support creates a more noticeable clinical difference. Use under age 18 isn't recommended due to insufficient safety data.
Should growth factor use differ in winter versus summer?
In winter, low humidity, cold wind, and dry indoor air raise TEWL; this increases the load on the barrier and makes growth factor support more valuable. Layering a growth factor serum with a ceramide- and cholesterol-rich repair moisturizer in winter both replenishes barrier lipids and supports repair signaling. In summer, since UV-driven EGFR activation is already high, moving the growth factor serum out of the morning routine and into evening-only use offers a more balanced approach by preventing excessive EGFR stimulation. Sunscreen use is mandatory in both seasons.
Do growth factor serums really work? Is there scientific evidence?
Yes, clinical evidence exists for topical growth factor application — though its magnitude and quality vary. A 2014 review by Fabi and Sundaram compiled randomized controlled trials reporting a 28-34% reduction in fine lines, a 19% increase in epidermal thickness, and a 20% rise in collagen density with 12 weeks of EGF serum use. While the penetration limitation is real, the "outside-in signaling" mechanism and increased permeability in damaged areas allow for a biological response even without full penetration. Growth factor serums are among the strongest candidates among anti-aging ingredients, but they aren't a miracle solution — they deliver the best results as part of a comprehensive barrier care protocol.Fabi & Sundaram, 2014
What are the side effects and safety profile of growth factor serums?
Topical growth factor serums are generally well tolerated; no serious side effects have been reported in clinical studies. Possible side effects include temporary redness, mild irritation, and itching linked to carrier ingredients in the formulation. Because growth factors increase cell proliferation, the theoretical question of whether they could support tumor growth has come up; but current data shows that topical EGF concentrations stay well below the threshold needed for a carcinogenic effect, and systemic absorption is negligible when applied to intact skin. That said, people with a known history of active skin cancer should consult a dermatologist about growth-factor-containing products.
When should you see a doctor while using growth factor products?
You should see a dermatologist in these situations: (1) Redness, swelling, or itching that doesn't resolve within 48 hours of using a growth factor serum. (2) A prior diagnosis of atopic dermatitis, psoriasis, or active rosacea — these conditions can alter the growth factor response. (3) A history of active skin cancer or use of immunosuppressive medication. (4) No expected result despite 3 months of regular use — this can point to another, undetected barrier issue. (5) During pregnancy and breastfeeding, since safety data on topical growth factors during these periods is limited, doctor approval should be obtained before use.
Where should growth factor serum go in a skincare routine?
Following the thin-to-thick layering principle, growth factor serums are generally applied after cleanser and toner, and before moisturizer and sunscreen. The practical order is: (1) Cleanser, (2) Toner/essence, (3) Growth factor serum — applied to damp or lightly moisturized skin, 2-3 drops patted in, with a 60-90 second wait, (4) A barrier-repairing moisturizer (containing ceramide + cholesterol), (5) Sunscreen (daytime). Avoid applying a growth factor serum in the same step as a high-concentration AHA/BHA toner or tonic; the acidic environment can denature the growth factor protein.
Does a growth factor serum work while the skin barrier is damaged?
The answer to this question is both "yes" and "no." On one hand, a damaged barrier becomes more permeable through the follicular channels and micro-cracks that growth factor serums use for penetration — this theoretically increases access. On the other hand, growth factor receptors downregulate in an inflammatory environment, disrupting signal transmission — reducing the application's effectiveness. The clinically correct strategy is: first calm the inflammation and repair the lipid matrix with barrier-repair ingredients like ceramide, cholesterol, and free fatty acids; then move to growth factor support. Once barrier health is restored, growth factor receptors' response capacity also normalizes.
Which is more effective, growth factor or retinol? What are the differences?
Growth factor and retinol work through different mechanisms, so a direct comparison can be misleading. Retinol converts to retinoic acid and activates the RAR/RXR nuclear receptors — this means a change at the gene level, with strong, well-documented effects on collagen production and keratinocyte differentiation backed by numerous studies. Growth factor, meanwhile, targets membrane receptors, creating a faster response cascade; it's especially strong for barrier repair and cell proliferation. In terms of tolerability, retinol carries an initial irritation risk, while growth factor is generally better tolerated. For those using both, a morning-growth-factor, evening-retinol protocol stands out as the most practical approach for both synergistic effect and reduced irritation risk.
How long does it take to see results with a growth factor serum?
With regular use, the first observable effects generally begin at 4-6 weeks: skin texture normalizing, reduced dryness, and increased overall radiance are among these first responses. More pronounced changes — reduced fine lines, increased epidermal thickness, and improved pigmentation — typically become measurable at 8-12 weeks. Most clinical studies are designed around a 12-week usage protocol. For results to last, the growth factor serum needs to stay part of the ongoing care routine without interruption; a significant portion of gains has been observed to reverse after a 3-month gap. Speed of results is directly tied to starting barrier condition, the user's age, and formulation quality.
How do you choose the best growth factor serum? What criteria matter?
When choosing an effective growth factor serum, keep these criteria in mind: (1) Ingredient transparency: the label should clearly state EGF, KGF, FGF, or TGF-β content; avoid vague terms like "growth factor complex." (2) Concentration: the effective threshold is 1-5 ppm; some brands don't disclose this information. (3) pH: make sure it falls in the 4.5-6.5 range; a high pH leads to protein denaturation. (4) Packaging: prefer opaque, airtight, pump-free glass or HDPE; growth factor stability drops in clear, open-mouth bottles. (5) Supporting actives: the presence of supporting ingredients like ceramide, hyaluronic acid, or panthenol strengthens the barrier and boosts the growth factor's effect. (6) Clinical evidence: a product or its active being backed by clinical study data increases confidence in the choice.
Do growth factors increase skin cancer risk?
This question has been debated in scientific circles, and current data points to the following conclusion: the concentrations found in topical growth factor serums, combined with intact skin's absorption capacity, fall far short of the systemic level needed for a carcinogenic effect. It's true that the EGF receptor is overexpressed in some cancer types, but that relates to high-dose intravenous or intratumoral growth factor exposure. Topical EGF's systemic absorption in healthy skin stays negligible, and an intact stratum corneum doesn't let most of these molecules through. That said, people with a history of active skin cancer, basal cell carcinoma, or melanoma should consult a dermatologist about growth factor serums, just as they would for any active ingredient.
Mine Ekber
CIRÈLL Formulation & Content Team
Content editor working alongside the CIRÈLL R&D team on skin barrier physiology topics. The scientific claims on this page are verified against peer-reviewed sources via PubMed/NCBI; the source list is below.
Scientific Sources
- Fabi S, Sundaram H. The potential of topical and injectable growth factors and cytokines for skin rejuvenation. Facial Plast Surg. 2014;30(2):157-171.
- Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev. 1998;9(2):153-165.
- Mehta RC, Fitzpatrick RE. Endogenous growth factors as cosmeceuticals. Dermatol Ther. 2007;20(5):350-359.
Related Blog Posts
Related Guides
CIRÈLL Barrier Repair Cream
The scientific skin barrier principles discussed in this article form the foundation of the CIRÈLL Biomimetic Tribarrier Cream formulation.
View the Product